Global Alzheimers Disease Therapeutics and Diagnostics Market Segments, Analysis & Forecast to 2025

Posted on 2018-06-28 by Mark Hub in Pharmaceuticals // 0 Comments

Market Research HUB

Albany, USA, 2018-Jun-28 — /EPR Network/ — Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Alzheimers Disease Therapeutics and Diagnostics Sales Market Report 2018” provides an in-depth analysis of the Alzheimers Disease Therapeutics and Diagnostics with the forecast of market size and growth. The analysis includes addressable market, market by volume, and market share by business type and by segment (external and in-house).The research study examines the Alzheimers Disease Therapeutics and Diagnostics on the basis of a number of criteria, such as the product type, application, and its geographical presence.

Click For Free Sample Research Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=1843138

This report studies the global Alzheimer’s Disease Therapeutics and Diagnostics market status and forecast, categorizes the global Alzheimer’s Disease Therapeutics and Diagnostics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Alzheimers disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimers disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimers Association, in 2016, an estimated 5.4 million Americans of all ages have Alzheimer’s disease. One in nine people aged 65 and above has Alzheimer’s disease. By 2050, the number of people aged 65 and above affected with Alzheimer’s disease is expected to nearly triple, from 5.2 million to an expected 13.8 million, excluding the development of medical advances to avert or cure the disease. The mortality rates due to Alzheimers disease are quite high. Between 2000 and 2013, deaths due to heart disease, stroke and prostate cancer decreased 14%, 23% and 11%, respectively, while deaths from AD increased 71% in the U.S. Similarly, According to Alzheimers disease International in 2015, there are an estimated 46.8 million people worldwide living with dementia and is further expected to grow in future. Thus, there is an increasing in the demand for Alzheimers therapeutics and diagnostics worldwide.

Population aging across the globe is a major factor driving the market for Alzheimers therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in number of aged population, and is associated with increased prevalence of chronic diseases like dementia. Therapies for AD offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease advancement. Thus, the magnitude of the affected population and lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers. However, identification of the primary reasons and mechanisms involved in AD are is limited. Drug manufacturers have been unable to validate significant clinical benefits of treatment for a numerous of new compounds due to strict regulations. One of the significant trend observed in this market is collaboration of the existing players. Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates which is further expected to propel the demand.

The global Alzheimer’s Disease Therapeutics and Diagnostics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Namenda
Aricept
Exelon
Solanezumab
Gantenerumab
Verubecestat
Pfizer
Eisai
Actavis
Lundbeck
Daiichi Sankyo
Novartis
TauRx

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Biomarkers
Cholinesterase inhibitors
NMDA receptor antagonists
Brain imaging
Blood tests
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Drugs Market
Diagnostics Market

Get Exclusive Full Report With Table of Content: https://www.marketresearchhub.com/report/global-alzheimers-disease-therapeutics-and-diagnostics-sales-market-report-2018-report.html

Table of Content:

Global Alzheimer’s Disease Therapeutics and Diagnostics Sales Market Report 2018
1 Alzheimer’s Disease Therapeutics and Diagnostics Market Overview
1.1 Product Overview and Scope of Alzheimer’s Disease Therapeutics and Diagnostics
1.2 Classification of Alzheimer’s Disease Therapeutics and Diagnostics by Product Category
1.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Biomarkers
1.2.4 Cholinesterase inhibitors
1.2.5 NMDA receptor antagonists
1.2.6 Brain imaging
1.2.7 Blood tests
1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Application/End Users
1.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Drugs Market
1.3.2 Diagnostics Market
1.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Market by Region
1.4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.3 Europe Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.4 China Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.5 Japan Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.6 Southeast Asia Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.4.7 India Alzheimer’s Disease Therapeutics and Diagnostics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Alzheimer’s Disease Therapeutics and Diagnostics (2013-2025)
1.5.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Growth Rate (2013-2025)
1.5.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Growth Rate (2013-2025)

2 Global Alzheimer’s Disease Therapeutics and Diagnostics Competition by Players/Suppliers, Type and Application
2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Competition by Players/Suppliers
2.1.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume and Value) by Type
2.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018)
2.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
2.3 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume and Value) by Region
2.3.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Sales and Market Share by Region (2013-2018)
2.3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Revenue and Market Share by Region (2013-2018)
2.4 Global Alzheimer’s Disease Therapeutics and Diagnostics (Volume) by Application

.. @@ Continued

Enquire About This Report: https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1843138

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick